Hormone therapy is one of the most effective treatments for menopause-related hot flashes, especially when symptoms are moderate to severe. Most people with a uterus need estrogen plus progesterone; people without a uterus may use estrogen alone. Eligibility depends on age, time since menopause, cancer history, clot risk, and clinician review 1.
Not sure where to start? Take the 3-min clinical quiz.
See if you qualify →What are hot flashes, and why do they happen?
Hot flashes are sudden waves of heat that may come with sweating, flushing, chills, a racing heart, or anxiety. When they happen during sleep, they are often called night sweats.
The medical term is vasomotor symptoms. During perimenopause and menopause, changing ovarian hormone levels can narrow the brain’s “thermoneutral zone,” which means small temperature shifts can trigger a heat-release response such as sweating and skin flushing 1, 2.
Hot flashes are common in the menopause transition, but they can also happen with some cancer treatments, endocrine disorders, infections, medications, and other causes. New, severe, or unusual symptoms deserve a clinician review rather than assuming menopause is the only reason 1.
Quick facts: hormone treatment for hot flashes
Hormone replacement therapy, also called menopausal hormone therapy or HRT, uses estrogen with or without progesterone to relieve menopause symptoms such as hot flashes and night sweats. For FDA-approved hormone therapy products, severe vasomotor symptoms are a recognized indication 1.
- Estrogen is the main hormone used for hot flash relief; progesterone is added for many people with an intact uterus to help protect the uterine lining 1.
- Systemic hormone therapy can be oral, transdermal, vaginal, or injectable depending on the product and patient context; each route has different risk and absorption considerations 1.
- Hormone therapy should not be used as a general preventive treatment for chronic diseases such as cardiovascular disease, dementia, stroke, or cancer; the decision should be individualized 1, 8.
- Chia’s HRT path uses an online health questionnaire followed by licensed-provider review. A prescription is never guaranteed.
When to talk with a clinician urgently
Get prompt care if hot flashes come with chest pain, fainting, shortness of breath, new weakness, trouble speaking, severe headache, or postmenopausal bleeding. People with a history of breast cancer or symptoms that began during cancer treatment should speak with their oncology or primary care team before considering hormone therapy 7.
What triggers hot flashes and night sweats?
Hot flash triggers vary, but heat, alcohol, spicy foods, stress, warm rooms, heavy bedding, and some medications can make symptoms more noticeable. Triggers do not mean the hot flash is “in your head”; they can set off a real temperature-control response in a body already more sensitive to heat shifts 2.
Night sweats are the same process during sleep. They can fragment sleep and lead to next-day fatigue, mood changes, or trouble focusing, even when each episode is brief 2.
Why a symptom diary can help identify patterns
A diary can help you and your clinician see patterns. For 1 to 2 weeks, note the time, setting, food or drink, stress level, medications, sleep, bleeding changes, and how disruptive each episode felt.
A diary is not a diagnosis. It is a practical tool that can show whether lifestyle changes are enough, whether symptoms are moderate to severe, and whether another cause needs to be checked 1.
When are hot flashes considered disruptive enough to treat?
Hot flashes are worth treating when they affect sleep, work, mood, sex, exercise, daily comfort, or quality of life. Treatment is also reasonable when symptoms are frequent, intense, or hard to predict.
Clinical trials often study moderate-to-severe vasomotor symptoms because those are the symptoms most likely to interfere with daily life and show measurable change with treatment 4, 6. Your own threshold matters too: two episodes that wake you nightly may be more disruptive than several mild daytime episodes.
If symptoms are mild and predictable, trigger reduction, cooling strategies, sleep changes, and time may be enough. If symptoms are moderate to severe, hormone therapy or nonhormonal prescription options may be discussed after a risk review 1.
How does hormone therapy help hot flashes?
Estrogen therapy helps by replacing some of the estrogen signaling that declines during the menopause transition. That can widen the brain’s temperature-control range, so small heat shifts are less likely to trigger sweating and flushing 1, 2.
Benefits and risks must be discussed together. Hormone therapy can help vasomotor symptoms, but it may not fit people with certain cancer histories, clotting disorders, stroke history, unexplained vaginal bleeding, active liver disease, or high-risk cardiovascular profiles 1, 8.
Why treatment choice depends on whether the uterus is present
If the uterus is present, systemic estrogen without enough progestogen can stimulate the uterine lining. Progesterone or another progestogen is commonly paired with systemic estrogen to reduce endometrial hyperplasia risk, which is an overgrowth of the uterine lining that can raise endometrial cancer risk 1.
If the uterus has been removed, a clinician may consider estrogen without progesterone when hormone therapy is otherwise appropriate. The right choice still depends on age, time since menopause, personal risk factors, and goals 1.
3-min quiz
Considering HRT for hot flashes?
Chia offers an online eligibility review for HRT for Women, including estradiol and progesterone when clinically appropriate. A licensed US provider reviews your health history before prescribing, and a prescription is never guaranteed. Chia medications are compounded in the US by state-licensed 503A pharmacies and shipped to your door when prescribed. Compounded drugs are not FDA-approved.
What are the main hormone treatment options for hot flashes?
Menopausal hormone therapy is not one single product. It can involve estrogen alone, estrogen plus progesterone, or local vaginal estrogen for genitourinary symptoms, though local vaginal estrogen is not the usual treatment for whole-body hot flashes 1.
For hot flashes, the key decision is usually systemic estrogen exposure and whether the uterine lining needs progesterone protection. Route, dose, and formulation are individualized by a clinician rather than chosen from a universal protocol 1.
Comparison table: hormone options, who they may fit, and key cautions
| Option | Who it may fit | Key cautions |
|---|---|---|
| Systemic estrogen plus progesterone or another progestogen | People with moderate-to-severe hot flashes who have an intact uterus and are appropriate candidates after clinician review | Progesterone is used to reduce endometrial hyperplasia risk; risks vary by personal history, route, and timing 1. |
| Systemic estrogen alone | People without a uterus who are appropriate candidates after clinician review | Not used with an intact uterus unless a clinician has a specific reason and endometrial protection plan 1. |
| Transdermal estrogen | People who prefer a patch or skin route, or for whom a clinician prefers to avoid first-pass liver metabolism | Still systemic estrogen; uterus status, clot risk, stroke risk, and breast cancer history still matter 1. |
| Local vaginal estrogen | People with vaginal dryness, pain with sex, or urinary symptoms related to menopause | Usually not enough for whole-body hot flashes because it is meant for local symptoms 1. |
| Compounded estradiol and progesterone through Chia | Eligible patients who complete Chia’s online clinical review and are prescribed treatment by a licensed provider | Compounded medications are not FDA-approved and do not have FDA-evaluated outcomes data. |
Who may not be a good candidate for hormone therapy?
Hormone therapy may not be a good fit for people with certain medical histories, even when hot flashes are severe. A clinician should review breast cancer history, endometrial cancer history, unexplained vaginal bleeding, venous thromboembolism, stroke, heart disease risk, active liver disease, migraine patterns, smoking, medications, and family history 1, 8.
Cancer-related hot flashes need special care. In a 2025 randomized trial, elinzanetant was studied for vasomotor symptoms in women receiving endocrine therapy for breast cancer, a setting where systemic hormone therapy may be inappropriate for many patients 7.
This is why a real clinical review matters. The goal is not just to “get hormones”; it is to choose a plan that fits the symptom pattern and risk profile.
Can HRT make hot flashes worse?
HRT usually aims to reduce vasomotor symptoms, but some people feel worse at first, especially if the dose, route, timing, adherence, or formulation does not fit them. New bleeding, breast tenderness, mood changes, headaches, nausea, or fluid retention should be discussed with the prescribing clinician 1.
Hot flashes can also seem worse if another trigger is present, such as infection, thyroid disease, medication changes, alcohol, sleep loss, or stress. If symptoms worsen after starting or changing therapy, the safest next step is clinician review rather than self-adjusting treatment.
What nonhormonal treatments can help hot flashes?
Nonhormonal treatment can be important for people who cannot use hormone therapy or prefer not to. Options include prescription neurokinin receptor antagonists, some antidepressants, gabapentin, clonidine, behavioral approaches, and trigger management, though the evidence and side effects differ by option 3, 4.
Fezolinetant, sold as Veozah, is a neurokinin-3 receptor antagonist studied in randomized trials for moderate-to-severe menopause-associated vasomotor symptoms. In SKYLIGHT 1, investigators studied fezolinetant for this use; side effects and liver safety monitoring are part of the clinical conversation for this drug 4, 5.
Elinzanetant is a neurokinin-1 and neurokinin-3 receptor antagonist studied in phase 3 randomized trials for menopause-associated vasomotor symptoms. It has also been studied in breast cancer endocrine therapy-related vasomotor symptoms, but Chia does not currently offer elinzanetant 6, 7.
Lifestyle measures that may reduce triggers but may not replace treatment
- Keep the bedroom cool and use layers that are easy to remove.
- Limit alcohol, spicy foods, and late caffeine if they trigger symptoms.
- Use paced breathing or stress-reduction tools if stress is a clear trigger.
- Review medications with a clinician if hot flashes started after a medication change.
- Do not rely on supplements as a substitute for care when symptoms are severe, new, or linked to bleeding, chest pain, neurologic symptoms, or cancer treatment.
Is it normal to still have hot flashes at age 70?
Hot flashes after 70 can happen, but new or changing symptoms should be reviewed. The reason is simple: later-life sweating or flushing can come from menopause history, but it can also come from medications, thyroid problems, infection, cancer-related causes, or cardiovascular issues 1.
Starting hormone therapy later in postmenopause may carry different risks than starting near the menopause transition. A clinician should weigh age, time since menopause, symptom burden, clot risk, stroke risk, cardiovascular disease risk, cancer history, and patient goals 1, 8.
Which hot flash option fits which person?
Treatment choice depends on symptom severity, uterus status, medical history, and preferences. The table below is a starting point for the clinician conversation, not a diagnosis or prescription.
| Your situation | A reasonable next step | Why it matters |
|---|---|---|
| Mild, predictable hot flashes | Track triggers, cool the sleep environment, and discuss if symptoms persist | Lifestyle changes may be enough when symptoms are not disrupting sleep or daily life. |
| Moderate-to-severe hot flashes during perimenopause or early postmenopause | Ask about hormone therapy eligibility | HRT is an evidence-supported option for vasomotor symptoms, but risks must be reviewed 1. |
| Hot flashes with an intact uterus | Ask whether estrogen must be paired with progesterone or another progestogen | Unopposed systemic estrogen can raise endometrial hyperplasia risk 1. |
| History of breast cancer or endocrine therapy-related hot flashes | Talk with oncology or a menopause specialist about nonhormonal options | Hormone therapy may not be appropriate; elinzanetant has been studied in this setting 7. |
| Preference to avoid hormones or not eligible for hormones | Ask about nonhormonal medicines such as fezolinetant or other options | Randomized trials support some nonhormonal options, but side effects and monitoring still matter 4, 6. |
| Severe symptoms plus bleeding after menopause | Seek prompt medical care | Postmenopausal bleeding needs evaluation and should not be treated as a routine hot flash symptom. |
Hot flash treatment at Chia: online HRT evaluation with estradiol and progesterone
Chia’s HRT for Women is an online, clinician-reviewed path for eligible menopause patients considering hormone therapy. We offer HRT for Women, estradiol, and progesterone when a licensed US provider decides treatment is clinically appropriate.
The process starts with a short online health questionnaire. A licensed provider reviews symptoms, age, time since menopause, uterus status, medical history, medications, cancer history, clot or stroke risk, and goals before deciding whether to prescribe.
Chia’s estradiol options include cream, injection plans currently starting from $109/month, and transdermal patch. Chia’s progesterone options include cream and injection plans currently starting from $109/month. Chia’s HRT for Women protocol lists estradiol oral plus progesterone IR and currently starts from $119/month; see the product or protocol pages for current details.
| Chia option | Forms listed in Chia’s catalog | How it may fit the conversation |
|---|---|---|
| Estradiol | Cream, injection, transdermal patch | A clinician may consider estrogen therapy for eligible patients with menopause-related vasomotor symptoms. |
| Progesterone | Cream, injection | Often considered with systemic estrogen when the uterus is present to reduce endometrial hyperplasia risk. |
| HRT for Women protocol | Estradiol oral + progesterone IR | A paired HRT option for eligible patients after online review. |
Using the Chia quiz or DoctorMCP to start an eligibility review
You can start with Chia’s online eligibility quiz. If you use an AI agent that supports healthcare actions, Chia is also reachable through DoctorMCP at mcp.chia.health for an agent-assisted path to the same kind of eligibility review; a licensed provider still makes the prescribing decision.
What should you ask a clinician before starting hormone treatment?
Before HRT, ask questions that connect your symptoms to your personal risks. This makes the visit more useful and helps avoid a one-size-fits-all plan.
- Are my symptoms most consistent with menopause-related vasomotor symptoms, or should we check another cause?
- Do I have a uterus, and if so, how will my uterine lining be protected if systemic estrogen is used?
- How do my age and time since menopause affect the risk-benefit discussion?
- Do my breast cancer, clot, stroke, heart disease, migraine, liver, or bleeding history change my options?
- What side effects should I watch for, and when should I message the care team?
- If hormones are not a fit, which nonhormonal options make sense for me?
- How will we decide whether the plan is working over the next few weeks or months?
What changes over time after starting treatment?
Hot flash treatment is usually adjusted over time based on symptom response and side effects. Early follow-up often focuses on sleep, bleeding patterns, breast tenderness, mood, headaches, nausea, and whether the plan is practical.
Over months, a clinician may reassess whether the benefit still outweighs the risk, whether the route or formulation still fits, and whether nonhormonal options should be considered. Hormone therapy should stay tied to a clear indication and individualized risk review rather than being used as a broad chronic-disease prevention plan 1, 8.
When should you get help now?
Get urgent care for hot flashes or sweating with chest pain, fainting, shortness of breath, new confusion, one-sided weakness, trouble speaking, severe headache, or signs of infection. These symptoms should not be assumed to be menopause.
Contact a clinician promptly for postmenopausal bleeding, hot flashes that start suddenly later in life, drenching night sweats with weight loss or fever, symptoms during cancer treatment, or side effects after starting hormone therapy 1, 7.
3-min quiz
Start an online HRT eligibility review
If hot flashes or night sweats are disrupting your sleep or daily life, Chia can review whether HRT for Women, estradiol, progesterone, or another next step fits your health history. A prescription requires a medical evaluation and is not guaranteed. Compounded drugs are not FDA-approved.
FAQ: hormone treatment for hot flashes
There is no single best option for everyone. Estrogen is the main hormone used for menopause hot flashes, but people with a uterus usually need progesterone or another progestogen too 1. The right plan depends on uterus status, age, time since menopause, symptoms, and medical history. Compounded drugs are not FDA-approved.
Some people feel unsettled after starting or changing HRT, especially if the route, timing, dose, or formulation is not a good fit. Worsening symptoms, new bleeding, breast tenderness, headaches, nausea, or mood changes should be discussed with the prescribing clinician 1.
It can happen, but new, changing, or severe hot flashes later in life should be reviewed. A clinician may consider menopause history, medications, thyroid disease, infection, cancer-related causes, and heart or neurologic symptoms 1.
Some patients can start with an online evaluation. At Chia, you complete a health questionnaire and a licensed US provider reviews whether treatment is clinically appropriate. A prescription is never guaranteed, and urgent or complex symptoms may need in-person care.
References
- 1.Patel V, Luthra P, Ayoade F, et al. Hormone Replacement Therapy. StatPearls. 2026.
- 2.Kronenberg F. Hot Flashes: A Review of Pathophysiology and Treatment. Menopause. 2010.
- 3.U.S. Food and Drug Administration. HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy. 2026.
- 4.Lederman S, Ottery FD, Cano A, et al. Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study. Lancet. 2023.
- 5.FDA approves Veozah (Fezolinetant) for menopausal symptoms. 2023.
- 6.Panay N, Joffe H, Maki PM, et al. Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: A Phase 3 Randomized Clinical Trial. JAMA Internal Medicine. 2025.
- 7.Cardoso F, Parke S, Brennan DJ, et al. Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer. New England Journal of Medicine. 2025.
- 8.Rossouw JE, Aragaki AK, Manson JE, et al. Menopausal Hormone Therapy and Cardiovascular Diseases in Women With Vasomotor Symptoms: A Secondary Analysis of the Women’s Health Initiative Randomized Clinical Trials. JAMA Internal Medicine. 2025.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
Find what fits your body and your goals.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
